Healthcare -
Biotechnology - NASDAQ - DE
$ 3.15
1.61 %
$ 707 M
Market Cap
6.43
P/E
CVAC - COST OF REVENUE
Cost of Revenue CVAC - CureVac N.V.
124 M
LAST VALUE
-27.74%
2 YEAR CAGR
47.61%
5 YEAR CAGR
0.00%
10 YEAR CAGR